PeptideDB

1-Benzylimidazole 4238-71-5

1-Benzylimidazole 4238-71-5

CAS No.: 4238-71-5

1-Benzyl-1H-imidazole is a biochemical compound that may be utilized as a biomaterial or organic/chemical reagent for bi
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

1-Benzyl-1H-imidazole is a biochemical compound that may be utilized as a biomaterial or organic/chemical reagent for biomedical research.

Physicochemical Properties


Molecular Formula C10H10N2
Molecular Weight 158.20
Exact Mass 158.084
CAS # 4238-71-5
PubChem CID 77918
Appearance White to off-white solid powder
Density 1.0±0.1 g/cm3
Boiling Point 310.0±11.0 °C at 760 mmHg
Melting Point 68-70 °C(lit.)
Flash Point 141.3±19.3 °C
Vapour Pressure 0.0±0.6 mmHg at 25°C
Index of Refraction 1.580
LogP 1.46
Hydrogen Bond Donor Count 0
Hydrogen Bond Acceptor Count 1
Rotatable Bond Count 2
Heavy Atom Count 12
Complexity 130
Defined Atom Stereocenter Count 0
SMILES

C1=CC=C(C=C1)CN2C=CN=C2

InChi Key KKKDZZRICRFGSD-UHFFFAOYSA-N
InChi Code

InChI=1S/C10H10N2/c1-2-4-10(5-3-1)8-12-7-6-11-9-12/h1-7,9H,8H2
Chemical Name

1-benzylimidazole
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro Benzylimidazole is a stimulator of UDP-glucosyltransferase and a selective inhibitor of thromboxane synthase. One cytochrome P450 enzyme is thromboxane synthase. Numerous reactions in drug metabolism and the synthesis of cholesterol, steroids, and other lipids are catalyzed by cytochrome P450 proteins. Hemostasis, heart disease, and stroke are just a few of the pathophysiological processes in which this enzyme is crucial. There are two transcript variants expressed by this gene. 1. Benzimidazole specifically prevents thromboxane synthase from functioning. Benzimidazole decreases TXB2 levels and improves blood flow in rats that have suffered a cerebral ischemia-reperfusion injury. In dose-dependent hepatitis in male Wistar rats, 1-benzimidazole (25, 75, and 100 mg/kg/day) was administered gastrically. 1. Benzimidazole 60–70% lowers plasma triglyceride levels. 1. Three distinct forms of UDP-glucuronyltransferase are stimulated by benzomidazole. 1-Benzimidazole exhibited a significant increase in activity against monoterpenoid alcohols such as nopol, 1-naphthol, morphine, and 4-methylthrinone. In a concentration-dependent manner, benamidazole raises hepatocyte CYP1A catalytic activity and CYP1A mRNA.
References

[1]. Effect of thromboxane synthase inhibition on eicosanoid levels and blood flow in ischemic rat brain. Stroke, 1989, 20(5): 627-632.

[2]. Effect of 1-benzylimidazole on cytochromes P-450 induction and on the activities of epoxy hydrolases and UDP-glucuronosyltransferases in rat liver. Biochemical pharmacology, 1988, 37(17): 3297-330 Shen RF, Tai H H. Thromboxanes: synthase and receptors. Journal of biomedical science , 1998, 5(3): 153-17.

[3]. Shen RF, Tai H H. Thromboxanes: synthase and receptors. Journal of biomedical science, 1998, 5(3): 153-17.

[4]. Induction of CYP1A by the N‐imidazole derivative, 1‐benzylimidazole. Environmental toxicity and chemistry, 2003, 22(4): 830-83.

Additional Infomation 1-benzylimidazole, an N-imidazole derivative, has been shown to have strong cardiotonic activity.

Solubility Data


Solubility (In Vitro) DMSO: 100 mg/mL (632.11 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (15.80 mM) (saturation unknown) in 10% DMSO + 40% PEG300 +5% Tween-80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 + to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 6.3211 mL 31.6056 mL 63.2111 mL
5 mM 1.2642 mL 6.3211 mL 12.6422 mL
10 mM 0.6321 mL 3.1606 mL 6.3211 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.